Clinical Trial Update: Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compared tegoprazan to esomeprazole-containing bismuth quadruple therapy for Helicobacter pylori eradication, reporting efficacy and sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Tegoprazan (tegoprazan)
• esomeprazole-containing bismuth quadruple therapy (esomeprazole-based bismuth quadruple therapy)

Snippet

Sponsor: Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: COMPLETED